From the Department of Medicine, Wright State University Boonshoft School of Medicine, Dayton, Ohio.
South Med J. 2021 Feb;114(2):77-80. doi: 10.14423/SMJ.0000000000001207.
The amount of colorectal cancer (CRC) screening using the noninvasive fecal immunochemical test (FIT) at a federally qualified health center, Five Rivers Health Clinic (Dayton, Ohio), has been low historically. Our quality improvement (QI) project aimed to improve CRC screening adherence in eligible patients who opted for FIT.
Three hundred ninety-two patients with FIT orders for CRC were screened during an 11-month period. The preintervention group (pre-I) was enrolled from December 1, 2018 to May 31, 2019, and the postintervention group (post-I) from June 1, 2019 to October 31, 2019. Three interventions were used: resident physicians trained during clinic meetings regarding FIT education for patients, posters displayed in patient rooms outlining the benefits of CRC screening, and standardized US mail reminder letters sent to FIT patients. Patient demographics and clinical variables were collected along with return rate.
The return rate for post-I was twice that of pre-I (74.4%, 95% confidence interval 64.6-82.3 vs 31.1, 95% confidence interval 26.2-36.6; < 0.001). The pre-I/post-I groups did not differ on demographic and clinical characteristics, and, except for race, none of these variables was associated with returning the FIT screening card.
The compliance rate for FIT completion and return more than doubled among our clinic patients after using a three-component QI intervention. Except for a difference in race, the lack of association between demographic and clinical characteristics with either pre-I/post-I group or return/no return of the FIT card leads us to conclude that our QI program for increasing FIT compliance is effective. Other settings where CRC screening is a prominent component of preventive care may benefit from adopting a similar QI intervention.
在联邦合格健康中心 Five Rivers Health Clinic(俄亥俄州代顿),使用非侵入性粪便免疫化学测试(FIT)进行结直肠癌(CRC)筛查的数量历来较低。我们的质量改进(QI)项目旨在提高选择 FIT 的合格患者的 CRC 筛查依从性。
在 11 个月的时间里,对 392 名有 CRC FIT 检查的患者进行了筛查。预干预组(pre-I)于 2018 年 12 月 1 日至 2019 年 5 月 31 日入组,干预后组(post-I)于 2019 年 6 月 1 日至 2019 年 10 月 31 日入组。使用了三种干预措施:在诊所会议期间对居民医生进行 FIT 患者教育培训、在患者房间内张贴概述 CRC 筛查益处的海报以及向 FIT 患者发送标准化的美国邮件提醒信。收集患者人口统计学和临床变量以及返回率。
post-I 的返回率是 pre-I 的两倍(74.4%,95%置信区间 64.6-82.3 与 31.1%,95%置信区间 26.2-36.6;<0.001)。pre-I/post-I 组在人口统计学和临床特征上没有差异,除了种族之外,这些变量都与 FIT 筛查卡的返回无关。
在使用三组分 QI 干预后,我们诊所患者的 FIT 完成和返回率提高了一倍以上。除了种族差异外,人口统计学和临床特征与 pre-I/post-I 组或 FIT 卡的返回/未返回之间没有关联,这使我们得出结论,我们增加 FIT 依从性的 QI 计划是有效的。其他 CRC 筛查是预防保健重要组成部分的环境可能会受益于采用类似的 QI 干预措施。